TREM1 and non-small cell lung carcinoma: Indeed, in human non-small cell lung cancer (NSCLC) increased TREM-1+ tumor-associated macrophages (TAMs) were linked with reduced survival, and inhibiting TREM-1 suppressed tumor growth in a mouse xenograft NSCLC model27,28.